BioProgress, FMC Corp. deal

BPRG agreed to restructure a 2003 deal under which FMC received an exclusive worldwide license to BPRG's NRobe oral drug delivery technology (see BioCentury, Oct. 27, 2003). BPRG is now eligible for 2...